TECTA

This brand name is authorized in Brazil, Canada, Ecuador, Hong Kong, Mexico

Active ingredients

The drug TECTA contains one active pharmaceutical ingredient (API):

1 Pantoprazole UNII 1AL13B11R4 - PANTOPRAZOLE MAGNESIUM

Pantoprazole is a substituted benzimidazole which inhibits the secretion of hydrochloric acid in the stomach by specific blockade of the proton pumps of the parietal cells. Read about Pantoprazole

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TECTA Εnteric-coated tablets	Health Products and Food Branch (CA)	MPI, CA: SPM

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A02BC02	Pantoprazole	A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BC Proton pump inhibitors
Discover more medicines within A02BC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 501105001112415, 501105002119413, 501105003115411, 501105004111411, 501105005118418, 501105006114416, 501105007110414, 501105008117412
Country: CA	Health Products and Food Branch	Identifier(s): 02267233
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 28416-03-08
Country: HK	Department of Health Drug Office	Identifier(s): 63999
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 675M2004